Phase 3 Study of Adjuvant V940 and Pembrolizumab in Resected Melanoma

Clinical Trial Grant

Duke Scholars

Principal Investigator April Kelly Scott Salama Medicine, Medical Oncology

Awarded By

Merck Sharp & Dohme

Start Date

November 21, 2023

End Date

November 29, 2028

Awarded By

Merck Sharp & Dohme

Start Date

November 21, 2023

End Date

November 29, 2028